Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia
| dc.contributor.author | Freites Martínez, Azael David | |
| dc.contributor.author | Apalla, Zoe | |
| dc.contributor.author | Shapiro, Jerry | |
| dc.contributor.author | Iorizzo, Matilde | |
| dc.contributor.author | Rudnicka, Lidia | |
| dc.contributor.author | Sicco, Kristen I. Lo | |
| dc.contributor.author | Nikolaou, Vasiliki | |
| dc.contributor.author | Pirmez, Rodrigo | |
| dc.contributor.author | Takwale, Anita | |
| dc.contributor.author | Fattore, Davide | |
| dc.contributor.author | Et.al. | |
| dc.date.accessioned | 2025-12-05T12:03:44Z | |
| dc.date.available | 2025-12-05T12:03:44Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Persistent chemotherapy-induced alopecia (pCIA) is a distressing side effect of antineoplastic agents, imposing significant psychological burdens on cancer survivors. Despite its impact, there are no standardized guidelines for diagnosis, prevention or management. To establish consensus-based definitions, diagnostic criteria, grading systems and management recommendations for pCIA. | |
| dc.description.filiation | UEM | |
| dc.description.impact | 8.0 Q1 JCR 2024 | spa |
| dc.description.impact | 2.154 Q1 SJR 2024 | spa |
| dc.description.impact | No data IDR 2024 | spa |
| dc.description.sponsorship | Sin financiación | |
| dc.identifier.citation | Freites‐Martinez, A., Apalla, Z., Shapiro, J., Iorizzo, M., Rudnicka, L., Lo Sicco, K., Nikolaou, V., Pirmez, R., Takwale, A., Fattore, D., Dulmage, B., Piraccini, B. M., Vano‐Galvan, S., Lacouture, M., Sibaud, V., & Starace, M. V. R. (2025). Expert consensus for prevention, diagnosis and management of persistent chemotherapy‐induced alopecia. Journal of the European Academy of Dermatology and Venereology, 39(12), 2039-2046. https://doi.org/10.1111/jdv.70021 | |
| dc.identifier.doi | 10.1111/jdv.70021 | |
| dc.identifier.issn | 0926-9959 | |
| dc.identifier.issn | 1468-3083 | |
| dc.identifier.uri | https://hdl.handle.net/11268/16575 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1111/jdv.70021 | |
| dc.rights.accessRights | embargoed access | |
| dc.subject.other | Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos | |
| dc.subject.other | Quimioterapia | |
| dc.subject.other | Prevención de enfermedades | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Cáncer | |
| dc.subject.unesco | Sistema endocrino | |
| dc.subject.unesco | Tratamiento médico | |
| dc.title | Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Expert consensus for prevention, diagnosis and management_2025.pdf
- Size:
- 282.15 KB
- Format:
- Adobe Portable Document Format

